By Jim BlackIt’s well known that the prostate-specific antigen (PSA) test used to screen for prostate cancer is imprecise. Elevations in PSA levels may signal prostate cancer, but they also may be due to nonmalignant prostate conditions. Further complicating the screening process is that several medications and a number of other modifiable … Read More
Jim Black has covered myriad health topics as a medical editor and writer for more than a decade. He has worked with experts from some of the leading hospitals in the U.S., including Cleveland Clinic, Mount Sinai Medical Center, and the University of Pittsburgh Medical Center. Since 2005, Black has served as executive editor of the Cleveland Clinic Men's Health Advisor. In that time, he has written about everything from prostate diseases and diabetes to cardiovascular disease, cancer, and a wide array of other men's health issues. Previously, he spent 15-plus years as a staff writer and editor for a daily newspaper.
When he's not writing and editing, the western Pennsylvania resident freelances as a graphic designer and moonlights as a part-time musician. He's also a devout fan of the Pittsburgh Penguins hockey team and other Steel City sports teams.